Breakfast / Luncheon Symposia
Breakfast Symposium 1
By Sanofi-Aventis

Chairperson: TBD
Friday 4 September | Room 4 (5F)

07:30-08:00

TBD TBD TBD
**There will be no Q&A time.


Breakfast Symposium 2
By LG Chem

Chairperson: TBD
Friday 4 September | Room 5 (5F)

07:30-08:00

Solution for optimal glycemic control in early and advanced stages of type 2 diabetes Tae Jung OH Seoul National University, Korea
**There will be no Q&A time.


Breakfast Symposium 3

Chairperson: Seung Wan RYU (Keimyung University, Korea)
Friday 4 September | Room 6 (5F)

07:30-08:00

Bariatric surgery using 3D scope Han Hong LEE The Catholic University of Korea, Korea
**There will be no Q&A time.


Luncheon Symposium 1
By MSD

Chairperson: TBD
Friday 4 September | Room 1 (3F)

12:40-13:10

The latest option for the treatment of type 2 diabetes Hye Jin YOO Department of Endocrinology and Metabolism, Korea University, Korea
**There will be no Q&A time.


Luncheon Symposium 2
By Alvogen

Chairperson: TBD
Friday 4 September | Room 2 (3F)

12:40-13:10

Observed improvements of comorbid conditions in obese patients utilizing combination phentermine plus topiramate extended release Santosh T. VARGHESE VIVUS Inc., USA
**There will be no Q&A time.


Luncheon Symposium 3

Chairperson: Soo Min AHN (Hallym University, Korea)
Friday 4 September | Room 3 (3F)

12:40-13:10

Bariatric training and education program in Australia Lilian KOW Adelaide Bariatric Centre, Australia
**There will be no Q&A time.


Luncheon Symposium 4
By Daewoong Pharmaceutical

Chairperson: TBD
Friday 4 September | Room 4+5 (5F)

12:40-13:10

TBD Soo LIM Seoul National University, Korea
**There will be no Q&A time.


Breakfast Symposium 4
By Chong Kun Dang Pharmaceutical

Chairperson: TBD
Saturday 5 September | Room 4 (5F)

07:30-08:00

TBD Bo-Yeon KIM Division of Endocrinology and Metabolism, Soonchunhyang University, Korea
**There will be no Q&A time.


Breakfast Symposium 5
By Handok

Chairperson: TBD
Saturday 5 September | Room 5 (5F)

07:30-08:00

The multiple benefits of SGLT-2i: Ideal option for Asian T2DM patients Sang Youl RHEE Department of Endocrinology and Metabolism, Kyung Hee University School of Medicine
**There will be no Q&A time.


Breakfast Symposium 6
By TBD

Chairperson: TBD
Saturday 5 September | Room 6 (5F)

07:30-08:00

TBD TBD TBD
**There will be no Q&A time.


Luncheon Symposium 5
By Novo Nordisk

Chairperson: TBD
Saturday 5 September | Room 1 (3F)

12:30-13:00

Liraglutide: Key opportunities beyond weight reduction Changhee JUNG Department of Endocrinology and Metabolism, University of Ulsan, Korea
**There will be no Q&A time.


Luncheon Symposium 6
By Eli Lilly and Company

Chairperson: TBD
Saturday 5 September | Room 2 (3F)

12:30-13:00

TBD TBD TBD
**There will be no Q&A time.


Luncheon Symposium 7

Chairperson: Jin-Jo KIM (The Catholic University of Korea, Korea)
Saturday 5 September | Room 3 (3F)

12:30-13:00

TBD Ali AMINIAN Cleveland Clinic, USA
**There will be no Q&A time.


Luncheon Symposium 8
By Takeda Pharmaceutical

Chairperson: TBD
Saturday 5 September | Room 4+5 (5F)

12:30-13:00

Effect of treatment with Pioglitazone/Alogliptin on beta cell function and insulin resistance in T2D Jae-hyuk LEE Department of Endocrinology and Metabolism, Myongji Hospital, Korea
**There will be no Q&A time.